Bancreek Capital Management trimmed its Thermo Fisher stake by 10%, selling 1,002 shares in Q1 while maintaining it as a top ...

Thermo Fisher's strong economic moat, slowing growth, and fair valuation. Valuation is reasonable, trading near decade-low ...

Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) ...

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc.

TMO's financials show profitability but lack a clear positive trend, creating ongoing pressure on the stock price and ...

This was the stock's second consecutive day of gains.

Valued at a market cap of $159.1 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science through ...